company background image
A243

HuonsKOSDAQ:A243070 Stock Report

Market Cap

₩517.5b

7D

-1.3%

1Y

-15.5%

Updated

27 Nov, 2021

Data

Company Financials +
A243070 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance6/6
Financial Health5/6
Dividends3/6

A243070 Stock Overview

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally.

Price History & Performance

Summary of all time highs, changes and price drops for Huons
Historical stock prices
Current Share Price₩48,100.00
52 Week High₩86,500.00
52 Week Low₩47,450.00
Beta0
1 Month Change-6.60%
3 Month Change-15.47%
1 Year Change-15.48%
3 Year Change-12.06%
5 Year Change54.05%
Change since IPO-14.02%

Recent News & Updates

Apr 20
Here's Why Huons (KOSDAQ:243070) Can Manage Its Debt Responsibly

Here's Why Huons (KOSDAQ:243070) Can Manage Its Debt Responsibly

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Mar 17
We Think That There Are Issues Underlying Huons' (KOSDAQ:243070) Earnings

We Think That There Are Issues Underlying Huons' (KOSDAQ:243070) Earnings

Huons Co., Ltd.'s ( KOSDAQ:243070 ) stock was strong after they reported robust earnings. We did some analysis and...

Shareholder Returns

A243070KR PharmaceuticalsKR Market
7D-1.3%-1.9%-1.5%
1Y-15.5%-30.5%9.7%

Return vs Industry: A243070 exceeded the KR Pharmaceuticals industry which returned -30.5% over the past year.

Return vs Market: A243070 underperformed the KR Market which returned 9.7% over the past year.

Price Volatility

Is A243070's price volatile compared to industry and market?
A243070 volatility
A243070 Average Weekly Movement3.1%
Pharmaceuticals Industry Average Movement4.8%
Market Average Movement5.9%
10% most volatile stocks in KR Market11.4%
10% least volatile stocks in KR Market3.3%

Stable Share Price: A243070 is less volatile than 75% of KR stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: A243070's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1965741n/ahttps://www.huons.com

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, circulatory system, respiratory system, adrenocortical hormone, enzyme, mineral, solvent, calcium, hemostatic, antidote, antibiotic, metabolic, hyaluronic acid, well-being, anticoagulant, and other tissue cell system products. It also provides eye drop and bio products, as well as medical devices.

Huons Fundamentals Summary

How do Huons's earnings and revenue compare to its market cap?
A243070 fundamental statistics
Market Cap₩517.50b
Earnings (TTM)₩54.44b
Revenue (TTM)₩425.65b

9.5x

P/E Ratio

1.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
A243070 income statement (TTM)
Revenue₩425.65b
Cost of Revenue₩184.50b
Gross Profit₩241.15b
Expenses₩186.71b
Earnings₩54.44b

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)5.06k
Gross Margin56.65%
Net Profit Margin12.79%
Debt/Equity Ratio24.2%

How did A243070 perform over the long term?

See historical performance and comparison

Dividends

1.1%

Current Dividend Yield

11%

Payout Ratio

Does A243070 pay a reliable dividends?

See A243070 dividend history and benchmarks
When do you need to buy A243070 by to receive an upcoming dividend?
Huons dividend dates
Ex Dividend DateDec 29 2021
Dividend Pay DateApr 18 2022
Days until Ex dividend31 days
Days until Dividend pay date141 days

Does A243070 pay a reliable dividends?

See A243070 dividend history and benchmarks

Valuation

Is Huons undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: A243070 (₩48100) is trading below our estimate of fair value (₩180769.11)

Significantly Below Fair Value: A243070 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: A243070 is good value based on its PE Ratio (9.5x) compared to the KR Pharmaceuticals industry average (26.8x).

PE vs Market: A243070 is good value based on its PE Ratio (9.5x) compared to the KR market (15.4x).


Price to Earnings Growth Ratio

PEG Ratio: A243070 is poor value based on its PEG Ratio (1.4x)


Price to Book Ratio

PB vs Industry: A243070 is overvalued based on its PB Ratio (1.9x) compared to the KR Pharmaceuticals industry average (1.8x).


Future Growth

How is Huons forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

6.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: A243070's forecast earnings growth (6.7% per year) is above the savings rate (3.6%).

Earnings vs Market: A243070's earnings (6.7% per year) are forecast to grow slower than the KR market (13.5% per year).

High Growth Earnings: A243070's earnings are forecast to grow, but not significantly.

Revenue vs Market: A243070's revenue (9.3% per year) is forecast to grow slower than the KR market (11.6% per year).

High Growth Revenue: A243070's revenue (9.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: A243070's Return on Equity is forecast to be low in 3 years time (19.9%).


Past Performance

How has Huons performed over the past 5 years?

11.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: A243070 has high quality earnings.

Growing Profit Margin: A243070's current net profit margins (12.8%) are higher than last year (10.6%).


Past Earnings Growth Analysis

Earnings Trend: A243070's earnings have grown by 11.9% per year over the past 5 years.

Accelerating Growth: A243070's earnings growth over the past year (26.8%) exceeds its 5-year average (11.9% per year).

Earnings vs Industry: A243070 earnings growth over the past year (26.8%) exceeded the Pharmaceuticals industry -18.2%.


Return on Equity

High ROE: A243070's Return on Equity (20.2%) is considered high.


Financial Health

How is Huons's financial position?


Financial Position Analysis

Short Term Liabilities: A243070's short term assets (₩231.0B) exceed its short term liabilities (₩104.9B).

Long Term Liabilities: A243070's short term assets (₩231.0B) exceed its long term liabilities (₩52.9B).


Debt to Equity History and Analysis

Debt Level: A243070's net debt to equity ratio (2%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if A243070's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: A243070's debt is well covered by operating cash flow (95.1%).

Interest Coverage: A243070's interest payments on its debt are well covered by EBIT (25.4x coverage).


Balance Sheet


Dividend

What is Huons's current dividend yield, its reliability and sustainability?

1.13%

Current Dividend Yield


Upcoming Dividend Payment

TodayNov 27 2021Ex Dividend DateDec 29 2021Dividend Pay DateApr 18 2022110 days from Ex DividendBuy in the next 31 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: A243070's dividend (1.13%) is higher than the bottom 25% of dividend payers in the KR market (0.78%).

High Dividend: A243070's dividend (1.13%) is low compared to the top 25% of dividend payers in the KR market (2.44%).


Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, A243070 has been paying a dividend for less than 10 years.

Growing Dividend: A243070 has only been paying a dividend for 3 years, and since then payments have fallen.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (10.8%), A243070's dividend payments are thoroughly covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: A243070's dividends in 3 years are forecast to be thoroughly covered by earnings (12.7% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Huons has no CEO, or we have no data on them.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Huons Co., Ltd.'s employee growth, exchange listings and data sources


Key Information

  • Name: Huons Co., Ltd.
  • Ticker: A243070
  • Exchange: KOSDAQ
  • Founded: 1965
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: ₩517.497b
  • Shares outstanding: 10.76m
  • Website: https://www.huons.com

Number of Employees


Location

  • Huons Co., Ltd.
  • #253C-902 Pangyo-ro
  • Bundang-gu
  • Seongnam-si
  • Gyeonggi-do
  • 13486
  • South Korea

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/11/27 08:36
End of Day Share Price2021/11/26 00:00
Earnings2021/09/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.